MELD score: Utility and comparison with king's college criteria in non-acetaminophen acute liver failure

Journal of the College of Physicians and Surgeons Pakistan

Volumn 22, Issue 8, 2012, Pages 492-496

  Parkash, Om ^a   Mumtaz, Khalid ^a   Hamid, Saeed ^a   Shah, Syed Hasnain Ali ^a   Wasim Jafri, S M ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

KCH criteria; MELD score; Non Acetaminophen induced acute liver failure

Indexed keywords

ACUTE LIVER FAILURE; ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INTERMETHOD COMPARISON; KINGS COLLEGE HOSPITAL CRITERIA; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NON ACETAMINOPHEN INDUCED ACUTE LIVER FAILURE; PAKISTAN; PREDICTIVE VALUE; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAUNDICE; LIVER FAILURE, ACUTE; MALE; MODELS, BIOLOGICAL; PAKISTAN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; YOUNG ADULT;

EID: 84865847203     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lee WM, Squires RH Jr., Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 2008; 47:1401-15.
2. Fontana RJ. Acute liver failure. In: Feldman M, Friedman L, Brandt L, editors. Feldman, Sleisenger and Fordtran's gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; p. 1993.
3. Williams R. Classification, aetiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996; 16:343-8.
4. Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KS, Tandon A, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23:1448-55.
5. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-9.
6. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-45.
7. Khan SA, Shah N, Williams R, Jalan R. Acute liver failure: a review. Clin Liver Dis 2006; 10:239-58, vii-viii.
8. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 1993; 17:124-7.
9. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26:62-8.
10. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen: induced liver injury. Hepatology 2007; 45:789-96.
11. Schmidt LE, Larsen FS. Blood lactate as a prognostic marker in acetaminophen: induced acute liver failure. Hepatology 2003; 37:1199-201.
12. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-71.
13. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-70.
14. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91-6.
15. Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen induced acute liver failure. Liver Int 2007; 27:329-34.
16. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King's College Hospital criteria. Liver Transpl 2007; 13:814-21.
17. Kremers WK, van IM, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pre-transplant and post-transplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39:764-9.
18. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342:273-5.
19. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3:282-98.
20. Aygen CBB, Fung JJ, Shakil AO. Application of MELD scoring system to predict prognosis in patients with acute liver failure. Hepatology 2003; 38:554A.
21. Yantorno SE, Trentadue JJ, Ruf AE. The model for end stage liver disease (MELD): a useful tool to assess prognosis in fulminant hepatic failure. Liver Transpl 2004; 10:822-8.
22. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Aetiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5:29-34.